Monday, February 19, 2018 9:10:27 AM
CP,
even though we know that the patents are required, and although we don't know the reasons yet why the current BODs made such a breadcrumb "upfront" money deal with Oncologie (which in itself will require answers all around ) and the only true answer that woukd suffice is that Peregrine, now CDMO gets all IP rights back if Oncologie can't do what they promised and again, we don't have the details of what they promised and if they proved up front their $$$ backers which are hidden to the public have a set of events lined up which guarantee total return revenue to CDMO shareholders that offset those big upfront monies and guarantees Oncologie can't further dilute true royalties / profits due CDMO and can't dilute manufacturing rights due CDMO
....to my point though is what about any other IP commercialization uses such as Bayer Crop Science may require PS Targeting IP and the entire animal Kingdom.....
Also other uses that help create new optimization techniques for alternative energy and I have made this point before but it is clear that the new knowledge learned regarding flipped PS and how it effects protein pathways ....will help further alternative energy research / production / water contamination / etc etc
Basically, we have no clue about the Oncologie contract and CDMO CEO Lias even saying "residual value..." just may be a way to limit retail jumping in (also evident with the Breadcrumb upfront money ) which does nothing for the pps at this time ...but all places CDMO in legal view for not adhering to full disclosure / fiduciary Duties, especially after all they received in certified letters requesting an open bidding system.
I hear ROTH gets paid for the "more" validation by key experts and KOLs and we also are not seeing that fair opinion/assessment report by ROTH
Treatment of contaminated water and China has the most polluted water ways in the world
Bioconversion of Phosphatidylserine by Phospholipase D
from Streptomyces racemochromogenes in a Microaqueous
Water-Immiscible Organic Solvent
Sheng CHEN, Lin XU, Yan LI, Ning HAO, and Ming YANy
College of Biotechnology and Pharmaceutical Engineering, Nanjing University of Technology,
Nanjing 210009, China
Received May 17, 2013; Accepted June 24, 2013; Online Publication, September 7, 2013
Recent CDMO News
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM